AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32653952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bell-shaped flow rate curve
Number of subjects: 250
Study 32653952 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged flow rate curve
Number of subjects: 250
Study 32653952 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluctuating flow rate curve
Number of subjects: 250
Study 32653952 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent flow rate curve
Number of subjects: 250
Study 32653952 — intervention group
Group type: EXPERIMENTAL
Intervention: Plateau flow rate curve
Number of subjects: 250
Study 32653952 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal voiding urodynamics
Number of subjects: 250
Study 32534658 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative poor sleep quality (measured by Pittsburgh Sleep Quality Index)
Number of subjects: 400
Study 32534658 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative state anxiety
Number of subjects: 400
Study 32534658 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 400
Study 32534658 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index > 30 kg/m2
Number of subjects: 400
Study 32534658 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary lifestyle
Number of subjects: 400
Study 35442771 — intervention group
Group type: EXPERIMENTAL
Intervention: HA‐GB (hyaluronic acid and ginkgo biloba) eyedrops 3 times a day for 4 weeks
Number of subjects: 40
Study 32487163 — intervention group
Group type: EXPERIMENTAL
Intervention: multimodal hand therapy
Number of subjects: 150
Study 32487163 — intervention group
Group type: EXPERIMENTAL
Intervention: therapeutic ultrasound
Number of subjects: 150
Study 32487163 — intervention group
Group type: EXPERIMENTAL
Intervention: combination therapy with both hand therapy and ultrasound therapy
Number of subjects: 150
Study 35745231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical supplements (omega‐3 fatty acids, anthocyanins, and alpha‐cyclodextrins) for 12 weeks
Number of subjects: 0
Study 35745231 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 0
Study 35745231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical supplements
Number of subjects: 0
Study 33631287 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble interleukin-6 receptor (sIL-6R)
Number of subjects: 89119
Study 33631287 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) and soluble glycoprotein 130 (sgp130)
Number of subjects: 89119
Study 33404760 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival air polishing with erythritol powder
Number of subjects: 40
Study 33404760 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic instrumentation
Number of subjects: 40
Study 32475634 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern radiotherapy delivery systems and treatment strategies
Number of subjects: 0
Study 32475634 — intervention group
Group type: COMPARATOR
Intervention: Conventional workflows for the management of patients requiring dentoalveolar surgery
Number of subjects: 0
Study 32475634 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised trial
Number of subjects: 0
Study 34806342 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinovac-CoronaVac vaccine
Number of subjects: 290
Study 34806342 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 290
Study 34806342 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 290
Study 34806342 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 290
Study 34806342 — intervention group
Group type: EXPERIMENTAL
Intervention: HCQ monotherapy
Number of subjects: 290
Study 34806342 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone and MMF
Number of subjects: 290
Study 34806342 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety analysis
Number of subjects: 290
Study 33506858 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudge (providing a paper form for free vaccine delivery and contacts for occupational health services)
Number of subjects: 161
Study 33506858 — intervention group
Group type: EXPERIMENTAL
Intervention: No nudge
Number of subjects: 161
Study 33506858 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 161
Study 32711523 — intervention group
Group type: COMPARATOR
Intervention: Melbourne INFANT Program (15-month, six session program)
Number of subjects: 480
Study 36151280 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentapen infiltration (slow flow rate of 1.8 mL/162 sec, ramp-up mode)
Number of subjects: 130
Study 36151280 — intervention group
Group type: COMPARATOR
Intervention: Traditional syringe infiltration (flow rate of 1.8 ml/60 sec)
Number of subjects: 130
Study 36151280 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentapen infiltration
Number of subjects: 130
Study 32876655 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 96
Study 32876655 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 96
Study 33647762 — intervention group
Group type: EXPERIMENTAL
Intervention: High heat capacity mattress (HHCM)
Number of subjects: 24
Study 33647762 — intervention group
Group type: COMPARATOR
Intervention: Low heat capacity mattress (LHCM)
Number of subjects: 24
Study 32592830 — intervention group
Group type: COMPARATOR
Intervention: Traditional resistance training (TRT)
Number of subjects: 66
Study 36055941 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine spray
Number of subjects: 90
Study 36055941 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice spray
Number of subjects: 90
Study 36055941 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 90
Study 33402161 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention involving a tailored physical activity and progressive resistance exercise program remotely delivered by a physiotherapist
Number of subjects: 156
Study 33402161 — intervention group
Group type: COMPARATOR
Intervention: Usual care involving referral to a range of care practices in the community
Number of subjects: 156
Study 32449003 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOXIRI with panitumumab
Number of subjects: 66
Study 32449003 — intervention group
Group type: COMPARATOR
Intervention: FOLFOXIRI without panitumumab
Number of subjects: 66
Study 36385033 — intervention group
Group type: EXPERIMENTAL
Intervention: New thrombectomy device - multisegment Mechanical Thrombectomy (MT) System
Number of subjects: 238
Study 36385033 — intervention group
Group type: COMPARATOR
Intervention: Solitare FR
Number of subjects: 238
Study 33715279 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBMC-EMD (test)
Number of subjects: 42
Study 33715279 — intervention group
Group type: COMPARATOR
Intervention: DBBMC (control)
Number of subjects: 42
Study 33715279 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (DBBMC and DBBMC-EMD)
Number of subjects: 42
Study 32060078 — intervention group
Group type: EXPERIMENTAL
Intervention: Stellant FLEX injector
Number of subjects: 10
Study 32060078 — intervention group
Group type: COMPARATOR
Intervention: Stellant injector
Number of subjects: 10
Study 36251060 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion Tensor Imaging (DTI)
Number of subjects: 92
Study 36251060 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Magnetic Resonance Spectroscopy (1H-MRS)
Number of subjects: 92
Study 36251060 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum Neuron-Specific Enolase (NSE)
Number of subjects: 92
Study 36251060 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Score at 72 hours
Number of subjects: 92
Study 36251060 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of FA, tNAA/tCr, NSE, motor score, and Epileptic Seizures (ES)
Number of subjects: 92
Study 33070354 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) (0.12%)
Number of subjects: 0
Study 33070354 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride (CPC) (0.05%)
Number of subjects: 0
Study 33070354 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt and water (NaCl)
Number of subjects: 0
Study 33070354 — intervention group
Group type: COMPARATOR
Intervention: Control (no rinse)
Number of subjects: 0
Study 33993473 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion (1.0 mg/kg/h after a loading dose of 0.3 mg/kg)
Number of subjects: 0
Study 33993473 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 0
Study 33826861 — intervention group
Group type: EXPERIMENTAL
Intervention: AppCoach
Number of subjects: 3
Study 33826861 — intervention group
Group type: EXPERIMENTAL
Intervention: AppAlone
Number of subjects: 3
Study 33826861 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 3
Study 32771434 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 3786
Study 32771434 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 3786
Study 36412328 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of 0.25% plain bupivacaine
Number of subjects: 50
Study 36412328 — intervention group
Group type: COMPARATOR
Intervention: 20 ml normal saline
Number of subjects: 50
Study 32071923 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week exercise program
Number of subjects: 74
Study 32071923 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 74
Study 35177432 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTION Respecting Choices (RC) ACP intervention
Number of subjects: 162
Study 35177432 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 162
Study 33887400 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Target Temperature Management (TTM) at 33 ± 1 °C for 48 hours
Number of subjects: 79
Study 32180131 — intervention group
Group type: EXPERIMENTAL
Intervention: Citicoline and vitamin B12 eye drops (OMK2®, Omikron Italia srl, Italy, 3 drops/day)
Number of subjects: 20
Study 32180131 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops containing hypromellose 0.3% (3 drops/day)
Number of subjects: 20
Study 36207894 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose vaccine
Number of subjects: 422
Study 36207894 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose vaccine
Number of subjects: 422
Study 36207894 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vaccine
Number of subjects: 422
Study 36207894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study 36207894 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 422
Study 32994466 — intervention group
Group type: EXPERIMENTAL
Intervention: Belotecan 0.5 mg/m2 for five consecutive days every 3 weeks
Number of subjects: 140
Study 32994466 — intervention group
Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m2 for five consecutive days every 3 weeks
Number of subjects: 140
Study 32994466 — intervention group
Group type: EXPERIMENTAL
Intervention: Belotecan
Number of subjects: 140
Study 32994466 — intervention group
Group type: COMPARATOR
Intervention: Topotecan
Number of subjects: 140
Study 34263581 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam 0.2 mg/kg (R1 group)
Number of subjects: 189
Study 34263581 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam 0.3 mg/kg (R2 group)
Number of subjects: 189
Study 34263581 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam 0.4 mg/kg (R3 group)
Number of subjects: 189
Study 34263581 — intervention group
Group type: COMPARATOR
Intervention: Propofol (P group)
Number of subjects: 189
Study 33172293 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved nutrition in early life
Number of subjects: 0
Study 33172293 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 33358691 — intervention group
Group type: EXPERIMENTAL
Intervention: lumacaftor/ivacaftor
Number of subjects: 70
Study 33358691 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 70
Study 32057103 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence cholangiography using 0.05 mg/kg indocyanine green
Number of subjects: 120
Study 32057103 — intervention group
Group type: COMPARATOR
Intervention: X-ray cholangiography
Number of subjects: 120
Study 35730711 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 111
Study 35730711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 33478452 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmatic public health intervention (contact registry, training, TB booklet)
Number of subjects: 184
Study 33478452 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare worker knowledge and perceptions
Number of subjects: 184
Study 36069654 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-assisted video-based education programme (VTPA) and counselling 3 days a week for 2 months
Number of subjects: 50
Study 36069654 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study 32788412 — intervention group
Group type: EXPERIMENTAL
Intervention: Stay Strong, Stay Healthy (SSSH)
Number of subjects: 46
Study 32788412 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking (WALK)
Number of subjects: 46
Study 32788412 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 46
Study 35917866 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium chloride (5 mmol)
Number of subjects: 391
Study 35917866 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 391
Study 32703270 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue dishware
Number of subjects: 18
Study 32703270 — intervention group
Group type: COMPARATOR
Intervention: White dishware
Number of subjects: 18
Study 32703270 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dishware conditions
Number of subjects: 18
Study 35887238 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric oxygen (10%, 15%, 30%, 100%)
Number of subjects: 48
Study 35887238 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (1.4 ATA, 2.5 ATA)
Number of subjects: 48
Study 35887238 — intervention group
Group type: COMPARATOR
Intervention: Control for CD146 and TSP
Number of subjects: 48
Study 32790002 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional role scenarios (e.g., health visitor and cot death)
Number of subjects: 369
Study 32790002 — intervention group
Group type: COMPARATOR
Intervention: Expanded role scenarios (e.g., firefighter and stopping smoking)
Number of subjects: 369
Study 34080572 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to relaxing music and meditating for 45 minutes before sexual intercourse (Group 1)
Number of subjects: 120
Study 34080572 — intervention group
Group type: COMPARATOR
Intervention: 30 mg dapoxetine (Group 2)
Number of subjects: 120
Study 32085792 — intervention group
Group type: EXPERIMENTAL
Intervention: Jakyakgamcho-tang (JGT)
Number of subjects: 30
Study 32085792 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32085792 — intervention group
Group type: COMPARATOR
Intervention: JGT and Placebo
Number of subjects: 30
Study 33945227 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 162
Study 33945227 — intervention group
Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 162
Study 33066804 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraforaminal ligaments
Number of subjects: 4
Study 33066804 — intervention group
Group type: COMPARATOR
Intervention: Nerve root traction load
Number of subjects: 4
Study 35908275 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 400 mg, 800 mg, or 1200 mg QD
Number of subjects: 1251
Study 35908275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1251
Study 34275398 — intervention group
Group type: EXPERIMENTAL
Intervention: Canaliculotomy with curettage and silicone tube intubation (Group B)
Number of subjects: 47
Study 34275398 — intervention group
Group type: COMPARATOR
Intervention: Canaliculotomy with curettage without silicone tube intubation (Group A)
Number of subjects: 47
Study 34275398 — intervention group
Group type: COMPARATOR
Intervention: Canaliculotomy without intubation (Group A)
Number of subjects: 47
Study 34275398 — intervention group
Group type: EXPERIMENTAL
Intervention: Canaliculotomy with intubation (Group B)
Number of subjects: 47
Study 33210278 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive four-week structured group relaxation-training program (sophrology's dynamic relaxation)
Number of subjects: 0
Study 33210278 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33197294 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant zoster vaccine (RZV)
Number of subjects: 29305
Study 33197294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29305
Study 32744380 — intervention group
Group type: EXPERIMENTAL
Intervention: janagliflozin 25 mg
Number of subjects: 36
Study 32744380 — intervention group
Group type: EXPERIMENTAL
Intervention: janagliflozin 50 mg
Number of subjects: 36
Study 32744380 — intervention group
Group type: EXPERIMENTAL
Intervention: dapagliflozin 10 mg
Number of subjects: 36
Study 32744380 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study 32883044 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based multicomponent intervention (7-month after-school program plus curricular physical education)
Number of subjects: 64
Study 32883044 — intervention group
Group type: COMPARATOR
Intervention: Usual curricular lessons
Number of subjects: 64
Study 36130222 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole almonds (56 g/d)
Number of subjects: 87
Study 36130222 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground almonds (56 g/d)
Number of subjects: 87
Study 36130222 — intervention group
Group type: EXPERIMENTAL
Intervention: Almonds (whole and ground pooled)
Number of subjects: 87
Study 36130222 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground almonds
Number of subjects: 87
Study 36130222 — intervention group
Group type: COMPARATOR
Intervention: Control muffin (isocaloric)
Number of subjects: 87
Study 35911237 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy with Acceptance and Commitment Therapy (CBT-ACT)
Number of subjects: 0
Study 35911237 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (primary care referral)
Number of subjects: 0
Study 32209338 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab 10 mg/kg every 2 weeks
Number of subjects: 713
Study 36078247 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent–Child Interaction Therapy (PCIT)
Number of subjects: 204
Study 36078247 — intervention group
Group type: COMPARATOR
Intervention: Services as Usual (SAU)
Number of subjects: 204
Study 35377157 — intervention group
Group type: EXPERIMENTAL
Intervention: Chocolate Touch DCB
Number of subjects: 313
Study 35377157 — intervention group
Group type: COMPARATOR
Intervention: Lutonix DCB
Number of subjects: 313
Study 32309889 — intervention group
Group type: EXPERIMENTAL
Intervention: Monochrome Superb Microvascular Imaging (mSMI)
Number of subjects: 41
Study 32309889 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Superb Microvascular Imaging (cSMI)
Number of subjects: 41
Study 32309889 — intervention group
Group type: COMPARATOR
Intervention: Color Doppler Imaging (CDI)
Number of subjects: 41
Study 32309889 — intervention group
Group type: COMPARATOR
Intervention: Power Doppler Imaging (PDI)
Number of subjects: 41
Study 36306368 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxy-CBA
Number of subjects: 73
Study 36306368 — intervention group
Group type: COMPARATOR
Intervention: MCQ-CBA
Number of subjects: 73
Study 36306368 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CBA formats
Number of subjects: 73
Study 33199228 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib plus cisplatin/carboplatin plus pemetrexed
Number of subjects: 66
Study 33199228 — intervention group
Group type: COMPARATOR
Intervention: Osimertinib monotherapy
Number of subjects: 66
Study 36050657 — intervention group
Group type: EXPERIMENTAL
Intervention: PlayOn!® playground curriculum implemented in intervention schools
Number of subjects: 14
Study 36050657 — intervention group
Group type: COMPARATOR
Intervention: Control schools (no intervention in year one)
Number of subjects: 14
Study 32995880 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) targeting the anterior intraparietal sulcus (aIPS)
Number of subjects: 0
Study 32995880 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Magnetic Resonance Imaging (fMRI) combined with TMS
Number of subjects: 0
Study 32995880 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 0
Study 33499521 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy kiosk (PK) treatments for 10 weeks
Number of subjects: 88
Study 33499521 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 oral supplement (OS) for 10 weeks
Number of subjects: 88
Study 36315843 — intervention group
Group type: EXPERIMENTAL
Intervention: TURKOVAC
Number of subjects: 222
Study 36315843 — intervention group
Group type: COMPARATOR
Intervention: CoronaVac
Number of subjects: 222
Study 34476464 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST) for depression over 2 months
Number of subjects: 108
Study 34476464 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 108
Study 34476464 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST) for depression
Number of subjects: 108
Study 32338580 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT)
Number of subjects: 1915
Study 32338580 — intervention group
Group type: COMPARATOR
Intervention: Systemic thrombolysis (ST)
Number of subjects: 1915
Study 36098893 — intervention group
Group type: EXPERIMENTAL
Intervention: Families First parenting program (10-week intervention)
Number of subjects: 736
Study 36098893 — intervention group
Group type: EXPERIMENTAL
Intervention: Families First parenting program
Number of subjects: 736
Study 36098893 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 736